Chlamydia psittaci inclusion membrane protein CPSIT_0844 elicits inflammatory IL-6 and IL-8 production in human monocytes via TLR2/TLR4 signaling pathways
Immunobiology · 2026
DOI: 10.1016/j.imbio.2026.153160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunobiology, 2026. Verfasst von Xiaoliang Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, China; Department of Clinical Laboratory, The Second …. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Interleukin-8, Toll-Like Receptor 4, Interleukin-6. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The respiratory disease caused by Chlamydia psittaci (C. psittaci) infection is often characterized by significant inflammation. In the present study, we demonstrated that the C. psittaci inclusion membrane protein CPSIT_0844 induced THP-1 cells to express IL-6 and IL-8. However, silencing of the Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) genes by using small interfering RNA (siRNA) and transfection with the dominant negative plasmid encoding MyD88 (pDeNy-hMyD88) were found to reduce the expression of IL-6 and IL-8 in THP-1 cells stimulated with CPSIT_0844. Furthermore, CPSIT_0844 induces IL-6 and IL-8 production by signaling pathways involving JNK, p38, and NF-κB in monocytes. Collectively, our findings identify CPSIT_0844 as a proinflammatory virulence factor that triggers IL-6 and IL-8 expression via a TLR2/TLR4-MyD88-dependent mechanism, culminating in the activation of MAPK and NF-κB pathways. This work provides crucial molecular insight into the inflammatory pathogenesis of C. psittaci infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, China; Department of Clinical Laboratory, The Second Affiliated Hospital, Hengyang Medical College, University of South Chi…
- Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, China.
- Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, China; Affiliated Hengyang Hospital of Hunan Normal University & Hengyang Central Hospital, Hengyang, China.
- Department of Clinical Laboratory, Nanhua Affiliated Hospital; University of South China, Hengyang, China.
- Clinical Microbiology Laboratory, Affiliated Hospital of Hunan University &Xiangtan Central Hospital, Xiangtan, China.
- Institute of Pathogenic Biology, Hengyang Medical College, University of South China, Hengyang, China; Department of Clinical Laboratory, Nanhua Affiliated Hospital; University of South China, Hengyang, China.
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Yan, X., Wang, B., Zheng, K., Luo, D., Li, Y., Xiao, J., Chen, Y., He, Z., Wen, Y., Wang, C., & Wu, Y. (2026). Chlamydia psittaci inclusion membrane protein CPSIT_0844 elicits inflammatory IL-6 and IL-8 production in human monocytes via TLR2/TLR4 signaling pathways. Immunobiology. https://doi.org/10.1016/j.imbio.2026.153160
Vancouver
Yan X, Wang B, Zheng K, Luo D, Li Y, Xiao J, et al. Chlamydia psittaci inclusion membrane protein CPSIT_0844 elicits inflammatory IL-6 and IL-8 production in human monocytes via TLR2/TLR4 signaling pathways. Immunobiology. 2026. doi:10.1016/j.imbio.2026.153160
BibTeX
@article{Yan2026,
author = {Yan, Xiaoliang and Wang, Buwei and Zheng, Kang and Luo, Dan and Li, Yumeng and Xiao, Jian and Chen, Yuqing and He, Zhangping and Wen, Yating and Wang, Chuan and Wu, Yimou},
title = {Chlamydia psittaci inclusion membrane protein CPSIT_0844 elicits inflammatory IL-6 and IL-8 production in human monocytes via TLR2/TLR4 signaling pathways},
journal = {Immunobiology},
year = {2026},
doi = {10.1016/j.imbio.2026.153160}
}
EUVIMED